Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Non-Current Deffered Revenue (2018 - 2024)

Historic Non-Current Deffered Revenue for Mesoblast (MESO) over the last 7 years, with Q4 2024 value amounting to $2.5 million.

  • Mesoblast's Non-Current Deffered Revenue changed 0.0% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.5 million for FY2024, which is 0.0% changed from last year.
  • Per Mesoblast's latest filing, its Non-Current Deffered Revenue stood at $2.5 million for Q4 2024, which was down 0.0% from $2.5 million recorded in Q2 2024.
  • Mesoblast's Non-Current Deffered Revenue's 5-year high stood at $2.5 million during Q1 2020, with a 5-year trough of $2.5 million in Q1 2020.
  • For the 5-year period, Mesoblast's Non-Current Deffered Revenue averaged around $2.5 million, with its median value being $2.5 million (2020).
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first plummeted by 7500.0% in 2020, then changed by 0.0% in 2021.
  • Over the past 5 years, Mesoblast's Non-Current Deffered Revenue (Quarter) stood at $2.5 million in 2020, then changed by 0.0% to $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024.
  • Its last three reported values are $2.5 million in Q4 2024, $2.5 million for Q2 2024, and $2.5 million during Q4 2023.